Artificial hip replacement
Conditions
Interventions
Experimental group:esketamine
Sponsors
Army Medical Center of PLA
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 40 to 75 years who are planning to undergo elective hip replacement; 2. American Society of Anesthesiologists (ASA) Grade I ~ II; 3. Agree to enter the study and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. With cognitive dysfunction or poor understanding ability, unable to communicate effectively; 2. Have a history or family history of mental disorders; 3. Recent use of narcotic analgesia, sedation, anti-anxiety or depression drugs; 4. Patients with uncontrolled hypertension, history of cerebrovascular accidents, increased intracranial pressure, and intracranial space occupying lesions; Glaucoma, hyperthyroidism, acute alcoholism or chronic addiction; 5. Allergic to local anesthetics or infected persons at the intended puncture site; Coagulation dysfunction; Allergic to sufentanil or esketamine.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual analogue scale; | — |
Countries
China
Contacts
Public ContactYan Hong
Army Medical Center of PLA
Outcome results
None listed